tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
Holding LEXX?
Track your performance easily

Lexaria Bioscience (LEXX) Income Statement

188 Followers

Lexaria Bioscience Income Statement

Last quarter (Q ), Lexaria Bioscience's total revenue was $84.00K, a decrease of -180.07% from the same quarter last year. In Q, Lexaria Bioscience's net income was $-2.18M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Aug 24Aug 23Aug 22Aug 21Aug 20
Total Revenue
$ 464.28K$ 464.28K$ 226.21K$ 255.40K$ 722.74K$ 384.54K
Cost of Revenue
$ 4.82K$ 4.82K$ 31.50K$ 71.84K$ 175.35K$ 99.38K
Gross Profit
$ 459.46K$ 459.46K$ 194.71K$ 183.56K$ 547.39K$ 215.41K
Operating Expense
$ 6.21M$ 6.21M$ 6.73M$ 6.80M$ 6.23M$ 4.36M
Operating Income
$ -5.75M$ -5.75M$ -6.53M$ -6.62M$ -5.69M$ -4.15M
Net Non Operating Interest Income Expense
$ 14.31K$ 14.31K$ 43.19K---
Other Income Expense
$ 69.83K$ 69.83K$ 221.69K$ 764.61K$ 1.52M$ -96.33K
Pretax Income
$ -5.81M$ -5.81M$ -6.71M$ -7.38M$ -4.16M$ -4.15M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -5.80M$ -5.80M$ -6.66M$ -7.50M$ -4.03M$ -3.93M
Basic EPS
$ -0.46$ -0.47$ -1.01$ -1.24-$ -45.00
Diluted EPS
$ -0.46$ -0.47$ -1.01$ -1.24-$ -45.00
Basic Average Shares
$ 49.54M$ 12.38M$ 6.61M$ 5.89M-$ 92.44K
Diluted Average Shares
$ 49.54M$ 12.38M$ 6.61M$ 5.89M-$ 92.44K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.10M--$ 6.87M$ -6.41M$ -4.46M
Net Income From Continuing And Discontinued Operation
$ -5.80M$ -5.80M$ -6.66M$ -7.50M$ -4.03M$ -3.93M
Normalized Income
$ -5.75M$ -5.75M$ -4.93M$ -5.43M$ -4.58M$ -2.99M
Interest Expense
------
EBIT
$ -5.81M$ -5.81M$ -6.71M$ -7.38M$ -4.16M$ -4.15M
EBITDA
$ -5.73M$ -5.73M$ -6.57M$ -7.28M$ -4.02M$ -4.00M
Currency in USD

Lexaria Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis